Vor Biopharma Inc — Quarterly Cash Flow (NASDAQ:VOR) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 115.99 M142.89 M109.31 M205.37 M176.24 M Total liabilities 43.04 M46.23 M43.24 M1.71 B2.4 B Total equity 72.95 M96.66 M66.07 M1.51 B2.23 B Total liabilities & shareholders' equities 115.99 M142.89 M109.31 M205.37 M176.24 M Total debt ————— Net debt —————

News

Vor Biopharma Inc. (VOR) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Vor Biopharma Inc. (VOR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:VOR) 2026-01-16

Micron Tech and Citigroup among market cap stock movers on Wednesday

Vor Biopharma adds two investment partners to board of directors

Vor Biopharma (VOR): Initiating Hold Rating On Durable Telitacicept MG Study Data

Vor Biopharma stock initiated with Buy rating at TD Cowen on promising telitacicept potential

Vor Bio raises $150 million in private placement to fund clinical trials

Vor Biopharma: J.P. Morgan Makes Bull Case After Corporate Actions Slam Stock Price (VOR)

JPMorgan initiates Vor Biopharma stock with Overweight rating on telitacicept potential

JPMorgan initiates Vor Biopharma stock with Overweight rating, $43 target

Vor Biopharma (VOR) Upgraded to Buy: Here's What You Should Know

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 1.18%